PortfoliosLab logoPortfoliosLab logo
ARMP vs. SGHT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARMP vs. SGHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Armata Pharmaceuticals Inc. (ARMP) and Sight Sciences, Inc. (SGHT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARMP achieves a 20.86% return, which is significantly higher than SGHT's -45.27% return.


ARMP

1D
-4.17%
1M
-22.94%
YTD
20.86%
6M
26.71%
1Y
293.26%
3Y*
67.68%
5Y*
13.44%
10Y*
-30.49%

SGHT

1D
0.00%
1M
2.84%
YTD
-45.27%
6M
-49.30%
1Y
7.96%
3Y*
-16.74%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARMP vs. SGHT - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ARMP
Armata Pharmaceuticals Inc.
20.86%239.46%-42.90%161.29%-77.37%44.21%
SGHT
Sight Sciences, Inc.
-45.27%117.86%-29.46%-57.74%-30.51%-47.55%

Correlation

The correlation between ARMP and SGHT is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Jul 16, 2021

0.05

Fundamentals

Market Cap

ARMP:

$277.26M

SGHT:

$234.11M

EPS

ARMP:

-$7.79

SGHT:

-$0.71

PS Ratio

ARMP:

62.43

SGHT:

2.88

Total Revenue (TTM)

ARMP:

$4.41M

SGHT:

$79.55M

Gross Profit (TTM)

ARMP:

$3.26M

SGHT:

$68.55M

EBITDA (TTM)

ARMP:

-$27.14M

SGHT:

-$36.32M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Armata Pharmaceuticals Inc.

Sight Sciences, Inc.

Often compared with ARMP:
ARMP vs. LXRXARMP vs. ABUS

Return for Risk

ARMP vs. SGHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARMP
ARMP Risk / Return Rank: 9191
Overall Rank
ARMP Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
ARMP Sortino Ratio Rank: 9292
Sortino Ratio Rank
ARMP Omega Ratio Rank: 9090
Omega Ratio Rank
ARMP Calmar Ratio Rank: 9393
Calmar Ratio Rank
ARMP Martin Ratio Rank: 9393
Martin Ratio Rank

SGHT
SGHT Risk / Return Rank: 4646
Overall Rank
SGHT Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
SGHT Sortino Ratio Rank: 5050
Sortino Ratio Rank
SGHT Omega Ratio Rank: 4949
Omega Ratio Rank
SGHT Calmar Ratio Rank: 4444
Calmar Ratio Rank
SGHT Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARMP vs. SGHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Armata Pharmaceuticals Inc. (ARMP) and Sight Sciences, Inc. (SGHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARMPSGHTDifference
Sharpe ratioReturn per unit of total volatility

+1.99

Sortino ratioReturn per unit of downside risk

+2.75

Omega ratioGain probability vs. loss probability

1.43

1.10

+0.33

Calmar ratioReturn relative to maximum drawdown

6.06

0.13

+5.93

Martin ratioReturn relative to average drawdown

16.33

0.25

+16.08

ARMP vs. SGHT - Sharpe Ratio Comparison

The current ARMP Sharpe Ratio is 2.09, which is higher than the SGHT Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of ARMP and SGHT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ARMPSGHTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.09

0.09

+1.99

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.12

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.24

-0.38

+0.14

Drawdowns

ARMP vs. SGHT - Drawdown Comparison

The maximum ARMP drawdown since its inception was -99.98%, roughly equal to the maximum SGHT drawdown of -96.70%. Use the drawdown chart below to compare losses from any high point for ARMP and SGHT.


Loading charts...

Drawdown Indicators


ARMPSGHTDifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-96.70%

-3.28%

Max Drawdown (1Y)

Largest decline over 1 year

-48.72%

-61.88%

+13.16%

Max Drawdown (3Y)

Largest decline over 3 years

-79.22%

-85.34%

+6.12%

Max Drawdown (5Y)

Largest decline over 5 years

-85.70%

Max Drawdown (10Y)

Largest decline over 10 years

-99.68%

Current Drawdown

Current decline from peak

-99.85%

-88.90%

-10.95%

Average Drawdown

Average peak-to-trough decline

-82.78%

-77.83%

-4.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.05%

31.69%

-13.64%

Volatility

ARMP vs. SGHT - Volatility Comparison

The current volatility for Armata Pharmaceuticals Inc. (ARMP) is 21.21%, while Sight Sciences, Inc. (SGHT) has a volatility of 27.37%. This indicates that ARMP experiences smaller price fluctuations and is considered to be less risky than SGHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARMPSGHTDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.21%

27.37%

-6.16%

Volatility (6M)

Calculated over the trailing 6-month period

80.14%

56.93%

+23.21%

Volatility (1Y)

Calculated over the trailing 1-year period

141.51%

84.37%

+57.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

113.74%

91.49%

+22.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

110.46%

91.49%

+18.97%

Dividends

ARMP vs. SGHT - Dividend Comparison

Neither ARMP nor SGHT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ARMP vs. SGHT - Financials Comparison

This section allows you to compare key financial metrics between Armata Pharmaceuticals Inc. and Sight Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M202220232024202520260
19.70M
(ARMP) Total Revenue
(SGHT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ARMP and SGHT have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SGHT has higher volatility (27.37%) compared to ARMP (21.21%). In terms of maximum drawdown, ARMP dropped -99.98% vs SGHT's -96.70%.

ARMP currently has the higher Sharpe Ratio (2.09 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARMP and SGHT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer